RTN4 and myeloid sarcoma: CSF concentrations of RTN-4 were significantly higher in patients with AD, PD, and MS than in the control group (p < 0.001, W = −7.673; p = 0.001, W = 5.305; and p = 0.009, W = 4.455; respectively) (Figure 2).